For startups, benefits of non-dilutive funding extend far beyond cash
Panelists at MedCity INVEST Precision Medicine said startups can gain valuable expertise and experience through the process of seeking out non-dilutive funding.
Five new life sciences startups at Philadelphia accelerator
Biobots, Freenome, LignaMed, Telesis and OriMAbs - all life sciences startups - have taken residence in Philadelphia's University Science Center accelerator. Their focuses range from cancer diagnostics to 3D bioprinting.
Where Will AI Deployment Benefit Payers the Most?
We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.